Cite
MLA Citation
Sarah Huet et al.. “BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.” American journal of hematology, vol. 92, no. 6, n.d., pp. 515–519. http://access.bl.uk/ark:/81055/vdc_100046177533.0x00002e